Sopharma AD Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Ognian Donev
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 23.6yrs |
CEO ownership | 8.1% |
Management average tenure | no data |
Board average tenure | 9.3yrs |
Recent management updates
Recent updates
Sopharma AD (BUL:SFA) Has A Somewhat Strained Balance Sheet
Apr 09Here's Why We Think Sopharma AD (BUL:3JR) Is Well Worth Watching
Feb 20How Many Sopharma AD (BUL:3JR) Shares Do Institutions Own?
Feb 05Should You Rely On Sopharma AD's (BUL:3JR) Earnings Growth?
Jan 22Sopharma AD (BUL:3JR) Has A Somewhat Strained Balance Sheet
Jan 06Sopharma AD (BUL:3JR) Share Prices Have Dropped 25% In The Last Three Years
Dec 22Should Sopharma AD (BUL:3JR) Be Part Of Your Dividend Portfolio?
Dec 07Are Investors Undervaluing Sopharma AD (BUL:3JR) By 29%?
Nov 19Should Sopharma AD (BUL:3JR) Be Part Of Your Dividend Portfolio?
Jul 07CEO
Ognian Donev (66 yo)
23.6yrs
Tenure
лв723,162
Compensation
Mr. Ognian Ivanov Donev, D.Sc. (Econ.), Ph D., serves as the Executive Chairman at Sopharma AD and Sopharma Trading AD and also served as Chief Executive Officer since September 2021 until November 2021. M...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman | 23.6yrs | лв723.16k | 8.09% BGN 80.7m | |
Deputy Chairman | no data | лв173.75k | 0.000090% BGN 897.3 | |
Director | 5.8yrs | лв252.59k | 0.0012% BGN 12.3k | |
Independent Director | 12.9yrs | лв120.00k | 0.24% BGN 2.4m | |
Director | 2.9yrs | no data | 0.012% BGN 120.4k |
9.3yrs
Average Tenure
60yo
Average Age
Experienced Board: SFA's board of directors are considered experienced (9.3 years average tenure).